Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. - Wikidata - wikimedia - TriplyDB

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

http://www.wikidata.org/entity/Q40392922

about

Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery State-dependent μ-opioid modulation of social motivation The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms The pharmacogenomics of pain management: prospects for personalized medicine Advances in Medications and Tailoring Treatment for Alcohol Use Disorder κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction Innate immune gene polymorphisms in tuberculosis The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths Pain genes Symbiotic relationship of pharmacogenetics and drugs of abuse.Whole transcriptome RNA-Seq allelic expression in human brain In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Mechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene.Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.Genotyping panel for assessing response to cancer chemotherapy.Patterns of evolutionary constraints on genes in humans.Expansion of the human mu-opioid receptor gene architecture: novel functional variants The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance.Pharmacogenetics of OPRM1.Lack of association between DRD2 and OPRM1 genotypes and adiposity.The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans.A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use.Sex heterogeneity in pharmacogenetic smoking cessation clinical trials OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.Evidence for population variation in TSC1 and TSC2 gene expression Effect of OPRM1 and stressful life events on symptoms of major depression in African American adolescents Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.

P2860

Q21284753-8B1CF9D6-620F-43FC-B0B8-BFD16F142875 Q21562378-AA5EC009-9BB8-4680-B24A-EDD0A1472803 Q22305623-F217A177-F724-4F64-B8AB-ADB1D989E057 Q24616528-A2CA9C03-CE12-4EFA-BD40-85DA4BF0DD31 Q24645469-FCA72418-4EDF-4182-96F5-2BD50A0CBA0D Q24658054-3761BBAE-8D7A-48FE-A589-15D740206A54 Q26765266-4C40F1F4-D238-4D81-983C-F137319EBD8D Q26799814-271333B2-E6C9-425E-892F-ED1DAAB46405 Q26864309-1303A081-FBE3-4A8B-9505-797242768D50 Q27000486-B19512D0-7F69-4228-AAEE-FC13F5422736 Q27024180-EE88AF69-BB97-4ABB-8A09-6E39C9E1CB5D Q27311002-18BE16C5-1DCD-4786-8480-88D1945239AA Q28289166-4AECFE9C-41FB-44A4-AA90-2292A49798BA Q28473018-672217D1-E879-41CE-B881-0A7C7ABD109E Q28476270-B3332CCF-36A6-4F33-A6AB-C8AE1B5FB202 Q28681164-490B2BF2-56FA-416D-B795-B8D099B35EDF Q28741473-70846B46-1382-4A3D-AA6F-87DA59114EEA Q30316113-F63DBC44-35E6-425A-8615-8567E153E17A Q30421563-9BFE72B3-4FE0-416C-84C6-1388C2AC036C Q30440516-775B9371-04B0-473C-A5B1-9FB956C157F3 Q33291238-E6C022AB-6C37-4695-BD79-C0A122960A6E Q33330500-916A8421-B6F0-4691-9283-D4049EE13D54 Q33343095-6380EA22-9C6D-458C-AC4A-90E29BAA37E1 Q33374403-0A7270F8-FA47-4267-A402-66B526A8C062 Q33395205-940CD833-DF1E-4641-BEF1-6AA2008311A4 Q33455500-1CE6E11F-FD84-46D7-9655-F4AA019765BE Q33533750-18DF35B4-B644-4BA1-A83D-E8BC1C49F579 Q33568294-AA9409EF-ED11-487D-B133-C875CD1C55C2 Q33570112-825E3609-2341-4F2E-A794-065FD92C5774 Q33598156-934C3974-5A1D-4C3D-AAF1-2D93F171045D Q33603061-EE47EA7A-1F02-4387-A61B-AF6AE42DAD86 Q33605769-722F1557-94EF-4C7C-BB1A-DB53FD8211B4 Q33624205-0A286B24-CB90-4239-A4C9-16B6D515C938 Q33742746-D3EB8F74-1F62-4517-A34F-60DEB07AB029 Q33797971-D543242F-BF7C-48BE-869E-630B61F8B78D Q33805049-494568F8-E45B-4CC9-9AFA-3A8D76935A65 Q33827600-5E42FD1F-8265-4238-92F6-1E41AB099998 Q33852618-5C351C97-A48E-45B0-A9C4-D6B6B9DC580A Q33913645-9DED8929-CB54-4607-92B1-5199DF9F5EE3 Q33921223-539CFDEC-4024-4B7A-A4BF-844BED1701A4

P2860

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

http://www.wikidata.org/entity/Q40392922

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

@en

type

label

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

@en

prefLabel

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

@en

P1433

Q40392922-1E087D79-79E4-4881-BDAF-82D51B985EE8

P1476

Q40392922-4840881C-DD1B-4856-AE20-1DBF556A3950

P2093

Q40392922-43B9BF43-6F14-42F2-914B-9FED9F7CFC19

Q40392922-5EA767C9-4D93-41E1-8D6F-031A62C3AE8F

Q40392922-632F9A8E-1103-4D13-9371-6A14861E5DBE

Q40392922-D278A5F3-42A4-414E-B7A9-5AC9FA23CE45

Q40392922-DF283498-50A6-4EBF-8AF8-B3B2462BB6F9

P2860

Q40392922-01A60741-3EB9-4A90-A9C3-9B9CF9319467

Q40392922-02C39C8D-B533-467A-97DF-CBF0405EB5B7

Q40392922-19577BB1-9CEC-4375-BDE2-DC710DB3EF1D

Q40392922-210F6A5C-6EA1-431B-A6BA-ECF4FA0514FF

Q40392922-25EACB13-7AA6-4C7F-B3F1-BDD9D4FAF250

Q40392922-2A83D391-6398-4538-A3AA-F8483AA6DF59

Q40392922-534F0925-D847-4D41-98CA-63DD824FAC79

Q40392922-58C689D5-98DD-4F56-AEA8-D33714DF842E

Q40392922-59DC7D53-A1EF-4891-9B90-FB83997703E6

Q40392922-5D1BA795-A9F8-4CFC-B607-C0AB93B34588

P304

Q40392922-B292C452-D097-4E5E-9CE5-59D597BB5CDF

P31

Q40392922-5E8CEBF1-7528-4E1D-BD79-4B77CFD2E7FE

P356

Q40392922-6DD9F327-59B1-49AB-B2EC-5168F9D99A3D

P407

Q40392922-4D967F5B-B034-40F4-B917-B1428C59661B

P433

Q40392922-6E351B89-36D2-4632-BF03-433C9A4F7DE7

P478

Q40392922-71DF2D85-FA2E-4DB1-B850-757FB050C271

P577

Q40392922-18D5F3E4-BF7E-4D3C-A3BB-A17C92331158

P698

Q40392922-F2A1CC7C-5EDF-4D81-B61F-F71304F1FC51

P921

Q40392922-C787206B-4302-4D28-94D1-F67C8ACAD89E

P356

P1433

Journal of Biological Chemistry

P1476

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

@en

P2093

Andrew D Johnson

http://www.w3.org/2001/XMLSchema#string

Audrey C Papp

http://www.w3.org/2001/XMLSchema#string

Danxin Wang

http://www.w3.org/2001/XMLSchema#string

Wolfgang Sadée

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

Mfold web server for nucleic acid folding and hybridization prediction

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions

Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics

SNP genotyping on pooled DNAs: comparison of genotyping technologies and a semi automated method for data storage and analysis.

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling.

Opioid receptor and peptide gene polymorphisms: potential implications for addictions.

Using reliability information to annotate RNA secondary structures.

Allelic variations in gene expression.

P304

32618-32624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M504942200

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16046395

http://www.w3.org/2001/XMLSchema#string

P921